Product NDC: | 51672-4022 |
Proprietary Name: | Acetazolamide |
Non Proprietary Name: | Acetazolamide |
Active Ingredient(s): | 125 mg/1 & nbsp; Acetazolamide |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51672-4022 |
Labeler Name: | Taro Pharmaceuticals U.S.A., Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040195 |
Marketing Category: | ANDA |
Start Marketing Date: | 19970528 |
Package NDC: | 51672-4022-1 |
Package Description: | 100 TABLET in 1 BOTTLE (51672-4022-1) |
NDC Code | 51672-4022-1 |
Proprietary Name | Acetazolamide |
Package Description | 100 TABLET in 1 BOTTLE (51672-4022-1) |
Product NDC | 51672-4022 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Acetazolamide |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 19970528 |
Marketing Category Name | ANDA |
Labeler Name | Taro Pharmaceuticals U.S.A., Inc. |
Substance Name | ACETAZOLAMIDE |
Strength Number | 125 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA],Sulfonamides [Chemical/Ingredient] |